Safety, quality & regulatory

What we honestly know about KPV safety, and what we do not

KPV looks unremarkable in preclinical tolerability studies, but preclinical tolerability is not human safety. There is no systematic human safety monitoring, no validated dose, and KPV is not an FDA-approved product: the FDA listed it in the 503A category 2 compounding safety-risk group until removing it in April 2026, but it is still not authorized for compounding. Product quality varies, and that variability can dominate any real-world experience.

This unit separates the reassuring parts from the genuine open questions, covers the US regulatory reality, and gives you a practical lens on sourcing red flags, all as education, not medical advice.